Znn3bq.jpeg
²é¿´: 1769  |  »Ø¸´: 9
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

entremed

Í­³æ (СÓÐÃûÆø)

[½»Á÷] ÄÉ˹´ï¿ËÉÏÊÐÍâÆóÕÐÆ¸CRAÒ»Ãû

¾ßÌ幤×÷µØµã:
±±¾© ³¯Ñô ºô¼ÒÂ¥
н½ð:
Óźñ
ÕÐÆ¸¸Úλ:
CRO£¬ÁÙ´²¼à²ìÔ±
ÁªÏµ·½Ê½:
010-65086067

ְλ:  ÁÙ´²¼à²éÔ±

ÈÎÖ°×ʸñ£º

•        ÉúÃü¿ÆÑ§Ïà¹Ø×¨Òµ´óר¼°ÒÔÉÏѧÀú
•        ¾ßÓÐ2ÄêÒÔÉϵÄCRA¡¢CRC»òÁÙ´²ÊÔÑéCRO¹«Ë¾µÄÏà¹Ø¹¤×÷¾­Ñ飬ÓÐÖ×ÁöÁÙ´²Ñо¿¼à²é¹¤×÷¾­ÀúÕßÓÅÏÈ
•        ÊìϤI/IIÆÚÁÙ´²ÊÔÑé¾ßÌåÁ÷³ÌºÍGCP¼°CFDAµÄÏà¹Ø·¨ÂÉ·¨¹æ£»ÓÐÍâ×ÊÒ©³§»ò¹ú¼Ê¶àÖÐÐÄÏîÄ¿¾­ÑéÕßÓÅÏÈ
•        ½ÏÇ¿µÄÈ˼ʹµÍ¨Óë×éÖ¯¹ÜÀí¼¼ÇÉ£¬¾ßÓÐÁ¼ºÃµÄ¹µÍ¨ºÍЭµ÷ÄÜÁ¦£¬ÉÆÓÚ´¦ÀíÓëÁÙ´²Ñо¿ÖÐÐŤ×÷ÈËÔ±µÄ¹ØÏµ£¬
•        ¾ßÓÐÁ¼ºÃµÄÖ°ÒµµÀµÂ¼°½ÏÇ¿µÄÔðÈÎÐÄ£¬¾ßÓжÀÁ¢¹¤×÷µÄÄÜÁ¦


ְλÃèÊö:
•        ²ÎÓëÖ´ÐÐÖÐÐÄÑ¡Ôñ¼°±ê×¼ÆÀ¼Û¹¤×÷£¬Ð­ÖúÁÙ´²ÊÔÑéµÄ×¼±¸¡¢Æô¶¯¡¢ÊµÊ©ºÍ¼à²é¹ÜÀí¹¤×÷£¬Ð­µ÷×éÖ¯Ñо¿Õß»áÒ飻

•        Ö´ÐÐÖÐÐÄÆô¶¯¼°¹Ø±Õ£¬ÅàѵµÈÏà¹Ø¹¤×÷£¬¶Ô¸÷Ñо¿ÖÐÐÄʵʩ³£¹æ·ÃÊÓ£¬ÔÚÑо¿ÖÐÐÄÓëÏîÄ¿¹ÜÀíÍŶÓÖ®¼ä±£³ÖÁ¼ºÃÓÐЧµÄ¹µÍ¨½»Á÷£¬ÎªÑо¿ÕßÌṩÓмÛÖµµÄ½¨ÒéºÍ°ïÖú¼°Ê±·´Ó³²¢½â¾ö´æÔÚµÄÎÊÌ⣻±£³ÖÓëËùÓÐÑо¿ÕßÖ®¼äÁ¼ºÃµÄºÏ×÷¹ØÏµ£¬Ð­µ÷ÊÔÑé¸÷·½¹ØÏµ£»È·±£Ñо¿ÖÐÐĵĸ÷Ï×÷·ûºÏGCP£¬ICH¼°SOPµÈ¸÷Ïî·¨¹æÖƶÈÒªÇó¡£

•        ºË²éÑо¿ÖÐÐĵÄԭʼÊý¾Ý£¬×¼±¸¡¢ÊÕ¼¯ËùÓÐÑо¿ÖÐÐÄÏà¹ØµÄÎļþ£¬½â¾ö¸÷ÖÖÓëÖ®Ïà¹ØµÄÎÊÌ⼰ʱ´¦Àí¸÷ÀàÊÔÑéÏà¹ØµÄÎÊÌ⣬ȷ±£ÁÙ´²ÊÔÑéÊý¾Ý¿ÆÑ§¿É¿¿²¢¼°Ê±ÊÕ¼¯£¬È·±£CRF¼Ç¼׼ȷ¡¢ÍêÕû£¬½øÐÐԭʼÊý¾ÝµÄºË¶Ô£¬°´ÒªÇó¼°Ê±Íê³É¼à²é±¨¸æ¡£

•        Эµ÷CROºÍ¸÷Ñо¿ÖÐÐĵŤ×÷£¬ÒÔÈ·±£°´ÕÕʱ¼ä±íÍê³É²¡ÀýµÄÈë×鹤×÷£¬È·±£Ñо¿ÖÐÐĵĽøÕ¹·ûºÏÑо¿¼Æ»®½ø¶ÈÒªÇó£»

  
ÎÒÃǽ«Ìṩ¸øÔ±¹¤£º
        Á¼ºÃ¹¤×÷·ÕΧ
        ÎåÏÕÒ»½ðµÈн×ʸ£Àû´ýÓö
        ¸÷ÖÖÅàѵºÍ·¢Õ¹¿Õ¼ä

Ó¢´´Ô¶´ï£¨±±¾©£©ÉúÎïÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾³ÉÁ¢ÓÚ2012Äê8Ô¡£ÎªÃÀ¹úNASDAQÉÏÊй«Ë¾,Ŀǰ¹«Ë¾¹É·ÝÔ¼2200Íò¹É£¬ÊÐÖµÔ¼3000ÍòÃÀÔª¡£ÖÂÁ¦ÓÚС·Ö×Ó°ÐÏòÖÎÁÆÖ×Áö¡¢×ÔÉíÃâÒß²¡µÄÐÂÒ©¿ª·¢¡£¹«Ë¾ÔÚÃÀ¹úÂíÀïÀ¼ÖÝÉèÓÐ×ܲ¿¡£°ì¹«µØµãΪ±±¾©Êг¯ÑôÇø¶«Èý»·£¬¹«Ë¾Ä¿Ç°ÔÚº£µíÇøÉèÁ¢ÊµÑéÊÒÖÂÁ¦ÓÚÐÂÒ©Ñз¢¡£
ĿǰÓÐ2¸ö²úÆ·ÔÚÃÀ¹ú¾­FDAÅú×¼½øÈëÁÙ´²Ñо¿×¨×¢Ð¡·Ö×Ó°ÐÏòÖÎÁÆÖ×Áö¡¢×ÔÉíÃâÒßµÄÐÂÒ©¿ª·¢£¬Ä¿Ç°ÒÑÓп¹ÈéÏÙ°©Ò»ÀàÐÂÒ©½øÈëIIÆÚÁÙ´²Ñо¿½×¶Î¡£
Ö÷ÒªÑо¿ÕßJennifer R. Diamond, ҽѧ²©Ê¿£¬ÃÀ¹ú¿ÆÂÞÀ­¶à´óѧҽѧԺ Ö×ÁöÑо¿ÖÐÐÄ£¬ÃÀ¹úÖøÃûÈéÏÙ°©×¨¼Ò¡£Ö÷ÒªÑо¿ÕßKathy Miller, MD£¬Ò½Ñ§²©Ê¿£¬ÃÀ¹úÓ¡µÚ°²ÄÉ´óѧҽѧԺ Ö×ÁöÑо¿ÖÐÐÄ£¬ÃÀ¹úÖøÃûÈéÏÙ°©×¨¼Ò¡£
Ö´Ðж­Ê³¤Wei-wu He ²©Ê¿£¬IDG×ʱ¾·çÏÕͶ×ʺϻïÈË£¬°ÁÈñ¶«Ô´£¨ÃÀ¹ú¡¢±±¾©¡¢ÎÞÎý£©¹«Ë¾¶­Ê³¤¡¢Ê×ϯִÐй٣¬¹þ·ð´óѧ²©Ê¿ºó£¬±´ÀÕҽѧԺ²©Ê¿£¬ÃÀ¹úÎÖ¶ÙÉÌѧԺ¹¤É̹ÜÀí˶ʿ¡£
Ê×ϯִÐй٣¬Ken Ren ²©Ê¿£¬ÃÀ¹úÂå¿Ë·ÆÀÕ´óѧ²©Ê¿ºó£¬Å¦Ô¼ÖÝÁ¢´óѧ²©Ê¿£¬Ç廪´óѧÖйúÆóÒµ¼Ò׿ԽÁìµ¼È˸߼¶ÑÐÐÞ°àÓÅÐãѧԱ¡£
¹«Ë¾Ä¿Ç°ÔÚ±±¾©Êк£µíÇøÖйشåÉúÎïÒ½Ò©ÔºÉèÁ¢ÊµÑéÊÒ£¬½øÐÐÐÂÒ©Ñз¢µÈÏîÄ¿¡£
CASI Pharmaceuticals¹«Ë¾ÊÇÈ«ÃÀ°©Ö¢Ñо¿»ù½ð»á°ä·¢µÄµÚÆß½ìÊ¥½Ý¶û¼ªµÄ×î´óÔÞÖúÉÌ¡£
CASI Pharmaceuticals, Inc. is a NASDAQ listed public company with a stock code: CASI. It is a clinical-stage pharmaceutical company employing a drug development strategy primarily in the United States and China to develop targeted therapeutics for the global oncology market. Its lead compound, ENMD-2076, a selective angiogenic kinase inhibitor, has completed several Phase 1 studies in solid tumors, multiple myeloma, and leukemia, and is currently completing a multi-center Phase 2 study in ovarian cancer. The Company has a wholly owned subsidiary, CASI Pharmaceuticals (Beijing) Co. Ltd., in Beijing, China with headquarters in Chaoyang business district. Additional information about CASI Pharmaceuticals is available on the Company's web site at www.casipharmaceuticals.com.
Ó¢´´Ô¶´ï£¨±±¾©£©ÉúÎïÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾
µØ    Ö·£º³¯ÑôÇøÏò¾ü±±Àï28ºÅÔº1ºÅÂ¥716ÊÒ   
ÓÊÕþ±àÂ룺100020
ÓÐÒâÏòµÄ¿ÉÒÔ·¢ËÍÓʼþµ½tomz@casipharmaceuticals.com »òÕß gloryli@casipharmaceuticals.com

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

entremed

Í­³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
2Â¥: Originally posted by ljqpyk at 2014-07-10 13:51:21

3Â¥2014-07-10 14:27:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð

entremed

Í­³æ (СÓÐÃûÆø)

😊😊😊😊😊😊😊😊😊😊😊

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
4Â¥2014-07-10 22:32:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

entremed

Í­³æ (СÓÐÃûÆø)

7Â¥2014-07-11 12:44:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

LuciferZero

ľ³æ (ÕýʽдÊÖ)

¡ï
entremed: ½ð±Ò+1 2014-07-15 10:05:02
Ò©ÎïÑз¢µÄС³æ°ï¶¥
8Â¥2014-07-15 07:10:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏÀà284µ÷¼Á +40 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-08 48/2400 2026-04-10 23:28 by 314126402
[¿¼ÑÐ] 290Çóµ÷¼Á +6 luoziheng 2026-04-10 6/300 2026-04-10 23:22 by babysonlkd
[¿¼ÑÐ] ²ÄÁÏ085601µ÷¼Á +25 ºÎÈó²É123 2026-04-10 27/1350 2026-04-10 23:17 by Ftglcn90
[¿¼ÑÐ] µ÷¼Á +12 ¾í¾í¾íÐIJË_ 2026-04-09 13/650 2026-04-10 22:36 by Ftglcn90
[¿¼ÑÐ] Çóµ÷¼Á +5 ²»»á·ÉµÄÓã@ 2026-04-10 5/250 2026-04-10 19:07 by chemisry
[¿¼ÑÐ] Ò»Ö¾Ô¸¾©Çø985£¬085401£¬Óë±¾¿Æ×¨ÒµÒ»Ö£¬µç×ÓÐÅÏ¢¹¤³Ì£¬ +4 Ñô¹â¿ªÀʵÄÄк¢ 2026-04-10 4/200 2026-04-10 18:27 by shenrf
[¿¼ÑÐ] 282£¬Çóµ÷¼Á +10 jggshjkkm 2026-04-09 12/600 2026-04-10 14:53 by ÄæË®³Ë·ç
[¿¼ÑÐ] 0702ÎïÀíѧѧ˶299Çóµ÷¼Á +6 ÆîÆâÁ¬ 2026-04-06 6/300 2026-04-10 11:10 by Roomoo
[¿¼ÑÐ] 085500Çóµ÷¼Á²ÄÁÏ +8 Ò×11122 2026-04-09 8/400 2026-04-09 23:15 by parmtree
[ÂÛÎÄͶ¸å] ÇóÖúÎÄÏ×Ô­ÎÄ 10+3 18500821399 2026-04-08 3/150 2026-04-09 16:56 by ±±¾©À³ÒðÈóÉ«
[¿¼ÑÐ] ²ÄÁÏר˶322 +14 ¹þ¹þ¹þºðºðºð¹þ 2026-04-05 14/700 2026-04-09 13:25 by 5268321
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +14 Ò»ÑùYWY 2026-04-06 14/700 2026-04-08 23:00 by Öí»á·É
[¿¼ÑÐ] ÉúÎïѧѧ˶£¬³õÊÔ351·Ö£¬Çóµ÷¼Á +4 ¡­¡«¡¢Íõ¡­¡« 2026-04-08 5/250 2026-04-08 21:49 by limeifeng
[¿¼ÑÐ] Ò»Ö¾Ô¸¼ª´ó»¯Ñ§327Çóµ÷¼Á +12 ÍõÍõ°×ʯ 2026-04-06 13/650 2026-04-08 16:05 by luoyongfeng
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +10 ŬÁ¦·Ü¶·112 2026-04-07 10/500 2026-04-08 15:01 by screening
[¿¼ÑÐ] ÇóÖú +3 ¿¨¿¨¶«88 2026-04-06 4/200 2026-04-06 15:28 by going home
[¿¼ÑÐ] Çóµ÷¼Á +10 chenxrlkx 2026-04-05 10/500 2026-04-06 11:31 by Öí»á·É
[¿¼ÑÐ] ¹¤¿Æ370Çóµ÷¼Á +3 äçÐļ弦µ° 2026-04-05 3/150 2026-04-06 10:55 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +4 ´Þwj 2026-04-04 5/250 2026-04-05 14:06 by imissbao
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦9£¬ÇóÉúÎïѧµ÷¼Á£¬326·Ö +6 Áõīī 2026-04-04 6/300 2026-04-04 19:44 by ÌÆãå¶ù
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û